Aldatu Biosciences
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
313 Pleasant St, Watertown, Massachusett...Phone Number
(617) 223-1866Website
www.aldatubio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
1
1
1
About Aldatu Biosciences
Aldatu Biosciences is the leader in adaptive PCR-based diagnostics for global health and emerging diseases, including COVID-19. The company's proprietary qPCR-enabling platform, PANDAA, uniquely adapts to DNA sequence instability in probe-binding regions. This makes the company's diagnostics tests ideal for rapidly mutating viruses such as SARS-CoV-2. Aldatu packages its diagnostics in kit form, and processes tests at its CLIA-certified laboratory. Aldatu's technology was developed at Harvard T.H. Chan School of Public Health. Aldatu is a Delaware-registered Public Benefit Corporation.Explore more
Aldatu Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aldatu Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Aldatu Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aldatu Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Aldatu Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Aldatu Biosciences has new funding data
Click to see if Aldatu Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aldatu Biosciences
Earning: See what the market has to say on Aldatu Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Aldatu Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Aldatu Biosciences
Compare insights from companies similar to Aldatu Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aldatu Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aldatu Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aldatu Biosciences.
Aldatu Biosciences Tech Stack
A closer look at the technologies used by Aldatu Biosciences
Aldatu Biosciences News & Media
Aldatu's SARS-CoV-2 Variant Genotyping Test differentiates between Omicron, Delta, and all other variants of concern.
WATERTOWN, Mass., Dec. 10, 2021 /PRNewswire/ -- Aldatu Biosciences (Watertown, MA) has confirmed that their PANDAA qDx SARS-CoVar (Variant Genotyping) Test Kit enables detection and allelic discrimination of variant lineage-defininig mutations. "Our focused genotyping approach of the S...Aldatu Begins Offering COVID-19 Testing Services for Health Care...
Boston-area Firm Offers Rapid Turnaround of Diagnostic Tests (PRWeb February 25, 2021) Read the full story at https://www.prweb.com/releases/aldatu_begins_offering_covid_19_testing_services_for_health_care_providers_employers_and_schools/prweb17751808.htm
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aldatu Biosciences
Sign Up For FreeTo access detailed company insights
Aldatu Biosciences is the leader in adaptive PCR-based diagnostics for global health and emerging diseases, including COVID-19. The company's proprietary qPCR-enabling platform, PANDAA, uniquely adapts to DNA sequence instability in probe-binding regions. This makes the company's diagnostics tests ideal for rapidly mutating viruses such as SARS-CoV... Read More
